A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDS
- Conditions
- HIV
- Interventions
- Behavioral: Peer Mentoring
- Registration Number
- NCT02025322
- Lead Sponsor
- Jury Candelario
- Brief Summary
This study aims to investigate the effectiveness of an in-person peer mentoring and health literacy intervention on improving medication adherence, HIV-1 viral load, CD4+ T lymphocyte counts, and HIV medical appointment attendance among newly-diagnosed and/or medication non-adherent HIV-positive individuals, compared to standard of care provider/staff-delivered education.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 36
All of the following criteria must be met for a participant to be eligible for the study:
- Confirmed diagnosis of HIV-1
- Newly diagnosed and initiating treatment (e.g., treatment naive) OR off medications for more than fourteen consecutive days (2 weeks) and re-initiating treatment OR currently on antiretroviral therapy with demonstrated ongoing adherence problems (missing more than 3 doses per month)
- Has a detectable (greater than 50 copies/ml) HIV-1 viral load
- Is able to obtain HIV medications during the entire study period (e.g., if uninsured, is enrolled in AIDS Drug Assistance Program).
Subject is ineligible for this study if:
- He/She suffers from cognitive impairment, active psychosis, or has a known history of harming others, OR
- He/She has a severe mental health and/or substance abuse condition that requires residential or inpatient treatment, OR
- The medical provider believes participation would not be in the best interest of the subject for other reasons.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Peer Mentoring Peer Mentoring Between baseline and 4-month follow-up, experiment group patients will be receiving (a) Weekly contacts with their Peer Mentor, with the option of receiving more frequent contact, if needed; and (b) 4 monthly, 1-hour workshops on HIV/AIDS, medication adherence, health literacy, and health and wellness. In addition, experiment group participants will also be provided with all standard practice services given to control group participants, including: (c) Two more or HIV basics education and medication adherence counseling sessions with their HIV specialty care provider and Patient Navigator; (d) resource referrals from a Patient Navigator based on the participant's needs; and (e) automated medical appointment reminders via phone.
- Primary Outcome Measures
Name Time Method Efficacy of Peer Mentoring on Improving Medication Adherence 4 months post-baseline Test the efficacy of a peer mentoring intervention on improving medication adherence among newly diagnosed and/or medication non-adherent HIV-positive individuals, compared to standard of care.
- Secondary Outcome Measures
Name Time Method Assess the Long-Term Impact of Peer Mentoring on Medication adherence 6-months post-baseline Assess the long-term impact of peer mentoring on medication adherence among newly diagnosed and/or medication non-adherent HIV-positive individuals, compared to standard of care.
Trial Locations
- Locations (1)
APAIT Health Center
🇺🇸Los Angeles, California, United States